Evidence map›Paper›PMID 41554734›Full record

ArticleNature communications2026

Genomic language model mitigates chimera artifacts in nanopore direct RNA sequencing.

Yangyang Li, Ting-You Wang, Qingxiang Guo, Yanan Ren, Xiaotong Lu, Qi Cao, Rendong Yang

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yangyang Li *Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0001-8224-1067
Ting-You Wang *Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0003-4354-3198
Qingxiang GuoDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0002-3694-3428
Yanan RenDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Xiaotong LuDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Qi CaoDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0002-5140-3681
Rendong YangDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. rendong.yang@northwestern.edu.ORCID 0000-0002-9512-2240

Funding

Targeting FOXA1-downstream pathways: a novel therapeutic strategy for castration-resistant prostate cancerP50CA180995 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABDULKADIR, SARKI A., HUSSAIN, MAHA H · 2015 to 2025
$19.9M
A novel role for EZH2 in PARP regulation and PARPi-resistance in prostate cancerR01CA285684 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Qi Cao, HENGYAO NIU · 2024 to 2026
$2.9M
A non-canonical role for EZH2 in rRNA methtlationR01CA256741 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CAO, QI · 2021 to 2025
$2.1M
Computational approaches to delineate non-canonical splicing eventsR35GM142441 · NIGMS · UNIVERSITY OF MINNESOTA · PI YANG, RENDONG · 2021 to 2025
$2.0M
A novel role for EZH2 in A-to-I RNA editing in prostate cancerR01CA278832 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Qi Cao, Kaifu Chen · 2024 to 2026
$2.0M
Genome-wide mapping and characterization of exitrons in human cancerR01CA259388 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Rendong Yang · 2022 to 2026
$1.8M
Combinational targeting histone and RNA modifications in prostate cancerR01CA300246 · NCI · NORTHWESTERN UNIVERSITY · PI Qi Cao, Rendong Yang · 2025 to 2026
$1.1M
NCI NIH HHS P50 CA180995NCI NIH HHS R01 CA256741NCI NIH HHS R01 CA259388NCI NIH HHS R01 CA278832NCI NIH HHS R01 CA285684NCI NIH HHS R01 CA300246NIGMS NIH HHS R35 GM142441U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA259388U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM142441
6 · The paper itself

Abstract

Chimera artifacts in nanopore direct RNA sequencing (dRNA-seq) introduce substantial inaccuracies, complicating downstream applications such as transcript annotation and gene fusion detection. Current basecalling models are unable to detect or mitigate these artifacts, limiting the reliability and utility of dRNA-seq for transcriptomics research. To address this challenge, we present DeepChopper, a genomic language model specifically designed to identify and remove adapter sequences from base-called dRNA-seq long reads with single-base precision. Operating independently of raw signal or alignment information, DeepChopper effectively eliminates adapter-bridged artifacts. Here, we show that DeepChopper enhances the accuracy of downstream analyses and unlocks the full potential of nanopore dRNA-seq, establishing it as a more robust tool for diverse transcriptomics applications.

Indexed as

ArtifactsGenomicsNanopore SequencingSequence Analysis, RNAAnimalsHumansLarge Language ModelsNanoporesReproducibility of ResultsSoftware

Identifiers

PMID41554734
PMCPMC12923543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.